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Abstract
Innate immunity is critically dependent on the rapid production of interferon in response to intruding viruses. The
intracellular pathogen recognition receptors RIG-I and MDA5 are essential for interferon induction by viral RNAs containing
59 triphosphates or double-stranded structures, respectively. Viruses with a negative-stranded RNA genome are an
important group of pathogens causing emerging and re-emerging diseases. We investigated the ability of genomic RNAs
from substantial representatives of this virus group to induce interferon via RIG-I or MDA5. RNAs isolated from particles of
Ebola virus, Nipah virus, Lassa virus, and Rift Valley fever virus strongly activated the interferon-beta promoter. Knockdown
experiments demonstrated that interferon induction depended on RIG-I, but not MDA5, and phosphatase treatment
revealed a requirement for the RNA 59 triphosphate group. In contrast, genomic RNAs of Hantaan virus, Crimean-Congo
hemorrhagic fever virus and Borna disease virus did not trigger interferon induction. Sensitivity of these RNAs to a 59
monophosphate-specific exonuclease indicates that the RIG-I-activating 59 triphosphate group was removed post-
transcriptionally by a viral function. Consequently, RIG-I is unable to bind the RNAs of Hantaan virus, Crimean-Congo
hemorrhagic fever virus and Borna disease virus. These results establish RIG-I as a major intracellular recognition receptor for
the genome of most negative-strand RNA viruses and define the cleavage of triphosphates at the RNA 59 end as a strategy
of viruses to evade the innate immune response.
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Introduction
The efficacy of the innate immune response against virus
infections is highly dependent on a rapid production of interferons
and other cytokines. To achieve this, all nucleated cells are
endowed with a cytoplasmic signaling cascade leading from the
detection of intruded virus particles to the expression of cytokines,
including type-I interferons (IFN-a/b) [1,2]. IFN-a/b directly
induce an antiviral state that alleviates the virus burden but also
initiate adaptive immune responses [3]. Viruses that block
expression of IFN-a/b are therefore often highly virulent [4,5].
An important group of pathogens causing emerging and re-
emerging diseases are viruses with a negative-stranded RNA
genome (NSVs). Prominent examples are influenza viruses (family
Orthomyxoviridae), Ebola virus (Filoviridae), rabies virus (Rhabdoviridae),
Nipah virus (Paramyxoviridae), Lassa virus (Arenaviridae), and several
members of the Bunyaviridae family e.g. Rift Valley fever virus,
Hantaan virus, or Crimean-Congo hemorrhagic fever virus
(Table 1). These pathogens can cause rapid, systemic and often
fatal illnesses which are characterized either by a fulminant
pneumonia and multi-organ failure or by a severe hemorrhagic
fever [6–9].
NSV particles consist of a lipid envelope and a genome which is
encapsidated by the viral nucleocapsid protein and polymerase.
The genome is present either as one continuous strand of RNA
(nonsegmented NSVs), or is divided into two, three, or up to eight
segments. Upon infection of a host cell, the NSV genome first
needs to be transcribed into mRNAs in order to furnish the
proteins necessary for virus replication. In the course of these
events, the incoming nucleocapsids must be unwrapped and the
genomic RNA exposed. Cells, in turn, are able to sense the
infection and activate an innate immune response. They
immediately synthesize cytokines, most prominently the antivirally
active type I interferons, but also other pro-inflammatory cytokines
and chemokines [10].
The main intracellular sensors to recognize viral RNA
structures and trigger cytokine synthesis are the RNA helicases
RIG-I and MDA5 [11–13]. Until very recently, it was assumed
that the only viral agonist of these pathogen recognition receptors
(PRRs) is double-stranded RNA (dsRNA) which is generated as a
PLoS ONE | www.plosone.org 1 April 2008 | Volume 3 | Issue 4 | e2032by-product of genome replication. However, we have recently
found that NSVs are exceptional in not producing substantial
amounts of dsRNA [14]. Instead, the genomic single-stranded
RNA (ssRNA) bearing a 59 triphosphate group was shown to be
sufficient to activate RIG-I dependent IFN-a/b induction [15,16].
The importance of RIG-I for recognizing genomic RNA has been
demonstrated for influenza virus, rabies virus and vesicular
stomatitis virus [15,16], but for none of the other NSVs.
Here, we tested genomic RNA isolated from highly pathogenic
NSVs to investigate whether activation of RIG-I is a common
denominator. Our results not only establish RIG-I as the main
intracellular sensor for the genome of both nonsegmented and
segmented NSVs, but also show that some viruses are able to
escape RIG-I-dependent cytokine induction by a hitherto
unrecognized stealth strategy.
Results
Genomic RNAs from highly virulent nonsegmented NSVs
activate the IFN system
We tested the genomic RNAs of Zaire Ebola virus (ZEBOV,
family Filoviridae) and Nipah virus (NiV, family Paramyxoviridae) for
the capability to activate an innate immune response. RNA
isolated from influenza A virus (FLUAV) particles was used as
positive control. As assessed in a reporter assay (Fig. 1A and B),
transfection of human 293T cells with RNAs isolated from
ZEBOV and NiV particles (vRNA) resulted in strong activation of
the IFN-b promotor, in a manner similar to FLUAV vRNA
(Fig. 1C). The constitutively active SV40 promoter, by contrast,
was not activated by vRNAs, indicating specificity for the IFN
system. Furthermore, RT-PCR analysis showed that treatment of
cells with vRNAs resulted in a transcriptional upregulation of the
IFN-b gene as well as the IFN-stimulated genes IP-10, ISG56 and
OAS1 (Fig. 1D), thus confirming our results with the reporter
system. We concluded from these data that genomic RNAs of
ZEBOV and NiV are potent elicitors of an IFN response.
Table 1. Negative-strand RNA viruses (NSVs).
Family
Genome
organisation Representative members
Filoviridae nonsegmented Zaire Ebola virus (ZEBOV)
Paramyxoviridae nonsegmented Nipah virus (NiV), measles virus (MeV)
Rhabdoviridae nonsegmented rabies virus, vesicular stomatitis virus
Bornaviridae nonsegmented Borna disease virus (BDV)
Arenaviridae 2 segments Lassa virus (LASV)
Bunyaviridae 3 segments Rift Valley fever virus (RVFV; Phlebovirus)
Hantaan virus (HTNV; Hantavirus)
Crimean-Congo hemorrhagic fever virus
(CCHFV; Nairovirus)
Orthomyxoviridae 6 to 8 segments influenza A virus (FLUAV)
doi:10.1371/journal.pone.0002032.t001
Figure 1. Genomic RNAs of ZEBOV and NiV activate the IFN response similar to FLUAV RNA. Human 293T cells were transfected with
luciferase reporter plasmids to measure activation of the inducible IFN-b promoter and the constitutively active SV40 promoter, respectively. At 6 h
post-transfection, cells were either mock treated or transfected with 1 mg viral genomic RNA (vRNA) of ZEBOV (A), NiV (B), or FLUAV (C). After
overnight incubation, cells were lysed and promoter activities were normalised to the mock-induced samples. Mean values and standard deviations
from 3 independent experiments are shown. (D) Detection of mRNAs for IFN-b (panel 1) and the IFN-stimulated genes IP-10, ISG56, and OAS (panels 2
to 4). Detection of c-actin mRNA served as control (panel 5). 293T cells were transfected with 1 mg vRNA or 5 mg of the dsRNA analog poly(IC) and
monitored 18 h later for gene upregulation by RT-PCR analysis.
doi:10.1371/journal.pone.0002032.g001
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group of genomic RNAs
MDA5 and RIG-I are the main intracellular PRRs driving an
antiviral innate immune response against RNA viruses [13]. To
investigate which of these factors is required for the recognition of
ZEBOV and NiV RNA, we established RNA interference (RNAi)
in 293T cells, using short hairpin RNAs (shRNAs) expressed by
retroviruses. Initially, for each target two different retroviral
shRNA constructs were tested for their efficiency to knock down
gene expression. In Fig. 2A it is demonstrated that the shRNA
constructs MDA5 #1 and RIG-I #2 significantly and specifically
reduced target expression levels, whereas MDA5 #2 and RIG-I
#1 had more modest effects. Therefore, in all subsequent
experiments, we used MDA5 #1 and RIG-I #2 for gene-specific
knockdowns. As a next step, we pretreated cells with these
constructs, incubated them for 5 days to establish RNAi, seeded
them again and transfected them with viral RNAs. The IFN-b
promoter assay was used as a representative measure of cytokine
induction. Fig. 2B shows that IFN induction by ZEBOV and NiV
vRNAs was affected when RIG-I was downregulated. By contrast,
MDA5 knockdown had no negative effect but sometimes increased
IFN induction to some - statistically not significant - extent.
RIG-I-dependent responses to FLUAV vRNA were previously
shown to critically depend on the presence of a 59 triphosphate
group [16]. In agreement with this, genomic RNAs from ZEBOV
and NiV particles lost their IFN-inducing activities when treated
with shrimp alkaline phosphatase (SAP). This effect could be
inhibited by EDTA, excluding an unspecific effect of SAP on IFN
induction (Fig. 2C).
These data suggest that the 59triphosphate group is the decisive
molecular pattern triggering a RIG-I-dependent IFN response to
genomic RNAs of ZEBOV and NiV.
Genomic RNAs of segmented NSVs differ in their ability
to trigger IFN induction
We extended our studies to NSV groups containing a
segmented genome. As highly relevant representatives we
investigated Lassa virus (LASV), a member of the Arenaviridae
family, and several members of the Bunyaviridae family, namely Rift
Valley fever virus (RVFV, genus phlebovirus), Hantaan virus
(HTNV, genus hantavirus), and Crimean-Congo hemorrhagic
fever virus (CCHFV, genus nairovirus). The RNAs of LASV and
RVFV activated the IFN-b promoter in a RIG-I- and 59
triphosphate-dependent manner as observed for the nonsegmen-
ted NSVs in the previous experiments (Fig. 3A and B).
Surprisingly, however, RNAs isolated from HTNV and CCHFV
particles did not trigger IFN induction (Fig. 3C). To rule out trivial
explanations for the lack of stimulatory activity, we confirmed the
identity and integrity of the bunyavirus genomic RNAs by RT-
PCR analysis (see below) and denaturing formaldehyde agarose gel
electrophoresis (Fig. 3D). Thus, in stark contrast to our findings
with the other NSVs, the genomic RNAs of bunyaviruses
belonging to the genera hantavirus and nairovirus are devoid of
an IFN-inducing activity.
Non-inducing viral RNAs contain a 59 monophosphate
The absence of IFN induction by hantaviral and nairoviral RNA
suggests a particular strategy to avoid RIG-I activation. As all initial
products of RNA polymerases contain a triphosphorylated 59 end
[17], we hypothesised that those viruses which possess non-
inducing genomic RNAs have removed the 59 triphosphate group.
In fact, for HTNV it was previously shown that the first nucleotide
of the genome 59 end is cleaved off by a viral endonuclease activity
(‘‘prime and realign’’), resulting in a monophosphorylated 59 end
[18]. To investigate whether CCHFV may follow a similar strategy,
we employed a 59-39 exonuclease which specifically digests ssRNA
having a 59 monophosphate [19]. As control, we incubated RVFV
RNA which should be protected from enzymatic degradation due
to its 59 triphosphate group. Fig. 4A shows that RVFV RNA can
still be detected after treatment with the 59 monophosphate-specific
RNase (panel 1), whereas HTNV RNA is degraded (panel 2). A
similar RNase sensitivity was observed with RNA from CCHFV
particles (panel 3). Thus, the inability of viral RNAs to activate
RIG-I-dependent IFN induction correlates with the presence of a
59 monophosphate.
An unusual mechanism of RNA replication was also proposed
for one other member of the NSVs, Borna disease virus (BDV)
[20,21]. Interestingly, RNA isolated from BDV particles was
unable to activate the IFN promoter, whereas RNA of measles
virus (MV) was a good inducer, as expected (Fig. 4B). Moreover,
BDV RNA, but not MV RNA, was undetectable after treatment
Figure 2. IFN induction by NSV vRNAs depends on RIG-I and
the 59 triphosphate group. (A) Verification of knockdowns. Human
293T cells were treated with retroviral shRNA constructs directed
against either RIG-I or MDA5, and cotransfected with expression
constructs for HA-tagged MDA5 (left panels) or GFP-fused RIG-I (right
panels). Western blot analysis using antibodies against the respective
fusion tags is shown. Detection of cellular b-tubulin was used as an
internal control. (B) Effect of shRNA knockdowns on IFN induction by
viral RNAs, using the reporter constructs and RNA transfection protocols
as described for Fig. 1A. The negative control shRNA construct (CTRL)
targets the heat shock 70 interacting protein and was tested to have no
effect on IFN induction (data not shown). (C) Genomic RNAs from
ZEBOV and NiV were either mock treated, treated with SAP, or treated
with SAP in the presence of the phosphatase inhibitor EDTA. IFN-b
reporter assays and RNA transfections were performed as described for
Fig. 1A. Mean values and standard deviations from 3 independent
experiments are shown.
doi:10.1371/journal.pone.0002032.g002
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the sole representative of the Bornaviridae family, avoids RIG-I
activation in a manner similar to HTNV and CCHFV, namely by
generating a 59-terminal monophosphate during the course of
genome replication.
Non-inducing viral RNAs are not bound by RIG-I
We wondered whether non-inducing vRNAs would differ from
inducing vRNAs in the ability to bind RIG-I. To investigate this,
we performed an RNA pulldown assay, using GFP-RIG-I coupled
to Sepharose beads (see Materials and Methods). These GFP-RIG-
I beads were incubated with vRNAs of either RVFV, HTNV,
CCHFV, or BDV. After extensive washing, RNAs were isolated
from the GFP-RIG-I beads and subjected to RT-PCR analysis.
Figure 3. Genomic RNAs of segmented NSVs. RNAs isolated from
virus particles of LASV (A) and RVFV (B) were tested for their ability to
activate the IFN-b promoter in dependency of RIG-I or MDA5 (left
panels) or 59 triphosphate groups (right panels). (C) IFN-b promoter
activation by genomic RNAs of the bunyaviruses RVFV, HTNV, and
CCHFV. Mean values and standard deviations from 3 independent
experiments are shown. (D) Purified virion RNAs (5 mg) of RVFV, HTNV,
and CCHFV were separated on denaturing formaldehyde agarose gels.
The genome segments (L, large; M, middle; S, small) are labeled on the
right, and asterisks indicate 28S and 18S rRNA bands. Contamination of
virus preparations with ribosomal RNAs are often observed [49] but
have no consequences for IFN induction. As a control RNA isolated from
ultracentrifuged supernatants of uninfected cells is shown (mock).
doi:10.1371/journal.pone.0002032.g003
Figure 4. Non-inducing viral RNAs contain a 59 monophos-
phate. (A) vRNAs of RVFV (panel 1), HTNV (panel 2) and CCHFV (panel
3) were incubated with a 59monophosphate-specific 59-39 exonuclease.
After 4 h of incubation, digestion efficacy was tested by RT-PCR analysis
using primer pairs specific for the viral S segment. A comparison with
untreated vRNAs is shown (lane input RNA). As additional controls, RNA
was incubated without enzyme (lane buffer) or H2O was used for RT-
PCR. The faint residual RT-PCR bands obtained after digestion of HTNV
or CCHFV vRNAs are most likely caused by a minority of RNAs
containing exonuclease-resistant 59-OH ends. Such 59-OH ends were
previously observed for HTNV vRNA and thought to represent a
preparation artifact [18]. (B) Activation of the IFN-b promoter by
genomic RNAs isolated from MV and BDV particles. Mean values and
standard deviations from 3 independent experiments are shown. (C)
Treatment of MV and BDV genomic RNAs with a 59 monophosphate-
specific 59-39 exonuclease and subsequent RT-PCR analysis.
doi:10.1371/journal.pone.0002032.g004
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RVFV was precipitated by the GFP-RIG-I beads, as expected.
SAP treatment abrogated RIG-I binding (data not shown), thus
confirming the dependency of the interaction on the 59-terminal
triphosphate group. In contrast to RVFV, particle RNAs of
HTNV, CCHFV and BDV were not bound by RIG-I (Fig. 5,
panels 2 to 4). These data support the notion that processing of
RNA 59 ends enables viruses to escape RIG-I signaling and,
hence, innate immune activation.
Taken together, our results demonstrate that the genomic RNAs
from several highly pathogenic NSVs trigger RIG-I-dependent
cytokine induction via their 59-terminal triphosphate group,
whereas MDA5 plays no apparent role. In addition, we have
uncovered that members of the Bunyaviridae and Bornaviridae have
evolved a unique strategy to escape this potent pathogen sensing
mechanism by removing the 59-terminal triphosphate group from
their genome.
Discussion
Viruseswith a negative-strandedRNA genome are responsible for
a wide range of diseases with significant medical and economical
impact. They are divided into groups having a nonsegmented
genome (Paramyxoviridae, Filoviridae, Rhabdoviridae, Bornaviridae)a n d
those having a segmented genome (Arenaviridae, Bunyaviridae,
Orthomyxoviridae). The genome replication strategy of NSVs involves
primer-independent initiation of RNA synthesis by a single
nucleotide. Due to this mechanism, all NSVs were believed to
contain a triphosphate group at the 59 ends of their genomic RNAs,
with the notable exception of hantaviruses for which a ‘‘prime and
realign’’ mechanism was described [18]. However, to our knowl-
edge, IFN-inducing 59 triphosphates have only been proven for the
RNAs of rabies virus and vesicular stomatitis virus (family
Rhabdoviridae) and FLUAV (family Orthomyxoviridae)[ 1 5 , 1 6 ] .H e r e ,
we undertook a systematic study of all remaining NSV families and
found that HTNV, CCHFV and BDV contain 59 monophosphates
whereas all other NSVs tested indeed had triphosphates. These
analyses suggest that the 59 triphosphate group may be a major
determinant of the massive cytokine responses which are observed
for infections with ZEBOV, NiV, LASV, and RVFV [9,22]. By
contrast, a recent study involving hantavirus-infected patients
showed that type I IFN levels did not increase during the course of
disease [23]. Moreover, IFN upregulation by CCHFV or BDV
infection were not reported so far.
In the recent years, an increasing number of viral proteins have
been described which are effectively downregulating the induction
of IFN and other cytokines, the so-called IFN antagonists [4,5].
Our results using genomic RNA from HTNV, CCHFV and BDV
establish the generation of 59-terminal monophosphates as a novel
strategy to avoid the activation of the IFN system. Interestingly,
the mechanisms of 59 end processing differ between the viruses.
HTNV employs prime-and realign to generate perfect comple-
mentary 59 and 39 genome ends able to form a panhandle
structure, whereas BDV uses genome trimming resulting in a
39end overhang [18,20]. The strategy by which CCHFV processes
its genome is currently unknown. However, viral RNA polymer-
ases are only able to initiate RNA synthesis with a purine, but not
with a pyrimidine [24], and CCHFV has 59-terminal pyrimidine
residues [25]. Moreover, for nairoviruses a previous study had
suggested that polymerase slippage occurs during RNA synthesis
[26]. These observations further support our claim that, for
genome replication, nairoviruses utilize a similar prime and realign
mechanism involving removal of the initiating 59 nucleotide as
hantaviruses do. The fact that the largely unrelated bunyaviruses
and bornaviruses apply apparently different means to reach the
same goal strongly suggests an independent evolution towards
genomic 59 monophosphates, driven by the selection pressure of
RIG-I and the antiviral IFN system. Strikingly, both HTNV and
BDV are known to establish persistent infection in their natural
hosts [21,27], and for CCHFV there is no evidence that it causes
overt disease in carrier animals [7]. Possibly, the absence of a RIG-
I ligand on the NSVs genome may facilitate the establishment of
persistent or inapparent infection.
All NSV groups which were found to possess 59 triphosphates,
namely paramyxoviruses, rhabdoviruses, filoviruses, arenaviruses,
orthobunya- and phleboviruses and orthomyxoviruses are known
to encode IFN antagonists acting on the level of IFN induction
[4,28–34]. Moreover, the fact that ssRNA with a triphosphory-
lated 59 end is an excellent trigger of RIG-I implies that an
increase in the number of genome segments contained within
infecting particles requires an increasingly strong and early anti-
IFN function as a counterbalance. Indeed, orthobunyaviruses and
phleboviruses, which have a tripartite genome, as well as the
influenza A virus which has eight segments express potent IFN
antagonists [4,29,35]. Interestingly, these segmented NSVs
dedicate particular non-structural proteins (NSs for Bunyaviruses,
NS1 for influenza virus) to silence the IFN system, whereas two-
segmented and nonsegmented NSVs mostly employ structural
proteins for this purpose [30–33]. This observation may implicate
that for NSVs with few genome segments and hence few RIG-I
ligands it is sufficient to endow structural proteins with an
additional IFN-antagonistic function, whereas a higher number of
genome segments requires either strong and specialized factors like
NS1 and NSs, or the removal of the RIG-I ligands. Moreover, the
fact that NSVs containing 59 triphosphates elicit strong cytokine
responses despite the presence of IFN-antagonistic proteins
indicates that the balance between induction and viral inhibition
is disturbed at some point during infection, possibly by a surplus of
non-functional genomes such as produced by defective interfering
particles [36] or by infection of cells which are resistant to the
action of viral IFN antagonists.
In addition to the removal of the RIG-I ligand, hantaviruses
modulate IFN induction by a weakly active NSs protein [37] and
Figure 5. vRNA binding by RIG-I. GFP-RIG-I expressed by 293T cells
was coupled to protein G Sepharose beads via a GFP-specific antiserum.
Beads were incubated with vRNAs of either RVFV, HTNV, CCHFV, or BDV.
After extensive washing, RNAs were extracted from the precipitates and
cDNA synthesis was performed using random hexanucleotide oligo-
mers. An aliquot of 10% of the input RNA was kept as RT-PCR control
(first lane). All precipitated RNAs were subjected to RT-PCR specific for
sequences of RVFV (panel 1), HTNV (panel 2), CCHFV (panel 3), and BDV
(panel 4). H2O was used as negative control.
doi:10.1371/journal.pone.0002032.g005
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the BDV P protein interferes with IFN induction [40], whereas for
CCHFV no IFN antagonistic protein has been identified so far.
The necessity to actively abrogate IFN induction despite the
absence of the 59triphosphate group may be due to the presence of
other viral structures which trigger an innate immune response,
e.g. viral nucleocapsids or traces of dsRNA which were shown to
play a role in NSV cytokine activation [41–45]. Moreover,
enveloped virus particles by themselves can activate IRF-3 in a
TLR- and RIG-I-independent manner [46,47], implicating that
mammalian hosts can respond to several independent hallmarks of
virus infection.
In summary, our study of the negative-stranded group of RNA
viruses revealed that genome recognition by RIG-I is indeed a
widespread phenomenon, but that hantaviruses, nairoviruses and
bornaviruses avoid induction of antiviral responses by processing
their RNA termini. These findings may help to better understand
viral pathogenesis and particular cytokine profiles observed during
infections.
Materials and Methods
Chemicals, cells and viruses
Puromycin (Sigma) was dissolved in H2Ot o2mg/ml and used
at a concentration of 2 mg/ml cell culture medium. Polyethylen
glycol (PEG) 8000 and poly(IC) were dissolved and used as
indicated by the manufacturer (Sigma). Simian VeroE6 cells and
human 293T cells were cultivated in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% FCS. Stocks of
FLUAV strain PR/8/34 were prepared under BSL-2 conditions
by culturing MDCKII cells in DMEM supplemented with 10%
bovine serum albumin, containing 1 mg/ml trypsine. RVFV strain
Clone 13, MV, and BDV were propagated in Vero cells under
BSL-2 conditions. HTNV strain 76-118 was propagated in
VeroE6 cells under BSL-3 conditions. NiV, ZEBOV strain
Mayinga, LASV strain Josiah, and CCHFV strain IbAr10200
were propagated in VeroE6 cells under BSL-4 conditions.
Plasmid constructs
The firefly luciferase reporter construct for monitoring IFN-b
promoter activation (p125Luc) was kindly provided by Takashi
Fujita, Kyoto University, Japan [48]. The control plasmid pRL-
SV40 (Promega) contains the Renilla luciferase gene under control
of the constitutively active SV40 promoter. Expression plasmids
pHA-MDA5 encoding human MDA5 fused to an N-terminal HA
tag and pGFP-RIG-I expressing human RIG-I fused to the C
terminus of EGFP were described previously [16].
Preparation of virus particles
Supernatants from infected cells were harvested at day 2
(CCHFV), day 3 (FLUAV, RVFV, NiV), day 4 (ZEBOV, MV),
day 7 (LASV), day 10 (HTNV), or day 60 (BDV) post-infection.
For preparation of virus particles, cell culture supernatants were
first pre-cleared from cell debris by centrifuging at 1500 rpm for
10 min and 4uC. Then, virus particles were concentrated either by
ultracentrifugation at 24,000 rpm for 2 h and 4uC (RVFV, MV,
BDV), ultracentrifugation at 45,000 rpm for 3.5 h at 4uC
(CCHFV, HTNV), or by PEG precipitation (FLUAV, NiV,
ZEBOV, LASV). IFN-inducing properties are not affected by the
method of virus concentration (data not shown). For PEG-
mediated particle precipitation, 175 ml of pre-cleared cell culture
supernatant were supplied with 12.25 g PEG 8000 and 4.02 g
NaCl and stirred overnight at 4uC. Then, samples were
transferred into 50 ml Falcons and centrifuged at 6,000 rpm for
45–60 min at 4uC. The pellet was dissolved in 1.5 ml of TriFast
reagent (Peqlab). RNA isolation was performed as described by the
manufacturer.
Transient transfections and reporter gene assays
Subconfluent 293T cell monolayers grown in 12-well dishes
were transfected with 0.25 mg p125-Luc and 0.05 mg pRL-SV40
in 100 ml OptiMEM (Gibco-BRL) containing 0.9 ml Fugene HD
(Roche). After 6 h at 37uC, the liposome-DNA mixture was
removed and cells were transfected either with 1 mg of viral RNA
or with 5 mg of poly(IC) using 3 ml Metafectene (Biontex) per mg
RNA prepared in 100 ml OptiMEM. At 18 h post transfection,
cells were harvested and lysed in 100 ml of Passive Lysis Buffer
(Promega). An aliquot of 20 ml lysate was used to measure
luciferase activities using the dual luciferase assay (Promega).
RT-PCR analysis
RNA was extracted using the TriFast reagent (Peqlab) and
treated with DNase I. Reverse transcription was performed with
200 U of RevertAid H Minus M-MuLV (Fermentas) and 200 ng
random hexanucleotides in 20 ml1 6 M-MuLV RT reaction
buffer supplied with 1 mM of each deoxynucleotide triphosphate
(dNTP) and 40 U RNase Inhibitor (Fermentas). The resulting
cDNA was amplified by 35 cycles of PCR, with each cycle
consisting of 30 sec at 95uC, 30 sec at 55uC, and 90 sec at 68uC,
followed by a final elongation step for 10 min at 68uC. Primer
sequences are available upon request.
shRNA knockdowns
Gene silencing by RNAi was achieved using shRNAs expressed by
retroviruses (shRNAmir constructs, Open Biosystems). The construct
which efficiently targets MDA5 had the catalog number RHS1764-
9494563 (MDA5 #1) whereas RIG-I was targeted with RHS1764-
9499511 (RIG-I #2). The control shRNA construct targets human
Hsp 70 interacting protein and contained the sequence RHS1764-
9500871. For establishing RNAi, 293T cells grown in 6-well dishes to
80% confluency were transfected with 1 mg each of pVpack-VSV G,
pVpack-GP (Stratagene) and the shRNA construct, subcultured,
incubated with Puromycin at day 3 post-transfection, and then
incubated for another 2 to 3 days before usage.
Enzymatic treatments of RNA
To remove 59-terminal phosphates, purified RNAs were treated
with 1 U of shrimp alkaline phosphatase (SAP) according to the
protocol of the manufacturer (Roche). After incubation at 37uC for
10 min in the presence or absence of the inhibitor 1 mM EDTA,
the enzyme was heat-inactivated at 65uC for 15 min.
Terminator
TM (Epicentre Biotechnologies) is a 59-39 exonucle-
ase able to digest ssRNA with a 59 monophosphate. To determine
the presence of a 59 monophosphate on genomic RNAs isolated
from virus particles, 500 ng of RNA were either mock treated or
incubated with 1 U of Terminator exonuclease for 4 h at 30uC.
The RNA was then purified using RNAeasy Mini Kit (QIAGEN),
eluated in nuclease-free H2O and treated with 1 U DNase
(Fermentas). To check for the presence of RNA, RT-PCR analysis
was performed as indicated above.
RNA pulldown analysis
Human 293T cells grown in 6-well dishes to 60% confluency
were transfected with 1 mg pGFP-RIG-I per well. After 40 h of
incubation, cells were washed with phosphate-buffered saline and
lysed for 10 min at room temperature in 200 ml of RIPA buffer
(50 mM Tris/HCl pH 7.5, 150 mM NaCl, 1% NP-40, complete
Viral RIG-I Escape
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of protein G Sepharose in RIPA buffer were preadsorbed with
5 ml polyclonal rabbit anti-GFP antiserum (Invitrogen) and
incubated for 2 h at 4uC. Then, the Sepharose beads were
washed three times with RIPA buffer and incubated for 2 h at 4uC
with the lysate equivalent of half a 6-well plate of transfected 293T
cells. The immunoprecipitates were washed three times with RIPA
buffer and then incubated with 1 mg of viral RNA for a further 2 h
at 4uC. After three washing steps using RIPA buffer, the volume of
the Sepharose beads was adjusted with H2O to 100 ml and RNA
was extracted using the RNeasy kit (Qiagen). RNA pulldown was
analysed by RT-PCR using random hexamers for RT and virus-
specific primers for PCR.
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